EQRx lands $500m Series B

EQRx, a developer of new medicines at lower prices, has raised $500 million in Series B financing.

EQRx, a developer of new medicines at lower prices, has raised $500 million in Series B financing. The company’s backers include GV, Arch Venture Partners, Andreessen Horowitz, Casdin Capital, Section 32, Nextech and Arboretum Ventures.

Source: Press Release